Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor

European Journal of Biochemistry

Volumn 239, Issue 2, 1996, Pages 349-355

  Gourlet, Philippe ^a   Vilardaga, Jean Pierre ^a   De Neef, Philippe ^a   Vandermeers, André ^a   Waelbroeck, Magali ^a   Bollen, Alex ^a   Robberecht, Patrick ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Pituitary adenylate cyclase activating polypeptide; Pituitary adenylate cyclase activating polypeptide receptors; Secretin; Secretin analogues; Secretin receptors

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; SECRETIN; SECRETIN DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HAMSTER; NONHUMAN; OVARY CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0030037104     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.0349u.x     Document Type: Article

References (44)

1. Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F. Jr, Lodish, H. F. & Goldring, S. R. (1991) Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science 254, 1022-1024.
2. Jüppner, H., Abou-Samra, A.-B., Freeman, M., Kong, X. F., Schipani, E., Richards, J., Kolakowski, L. F. Jr, Hock, J., Potts, J. T. Jr, Kronenberg, H. M. & Segre, G. V. (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254, 1024-1026.
3. Chen, R., Lewis, K. A., Perrin, M. H. & Vale, W. W. (1993) Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl Acad. Sci. USA 90, 8967-8971.
4. Ishihara, T., Nakamura, S., Kaziro, Y., Takahashi, T., Takahashi, K. & Nagata, S. (1991) Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 10, 1635-1641.
5. Patel, D. R., Kong, Y. & Sreedharan, S. P. (1995) Molecular cloning and expression of a human secretin receptor. Mol. Pharmcol. 47, 467-473.
6. Pisegna, J. R. & Wank, S. A. (1993) Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc. Natl Acad. Sci. USA 90, 6345-6349.
7. Hosoya, M., Onda, H., Ogi, K., Masuda, Y., Miyamoto, Y., Ohtaki, T., Okazaki, H., Arimura, A. & Fujino, M. (1993) Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). Biochem. Biophys. Res. Commun. 194, 133-143.
8. Svoboda, M., Tastenoy, M., Ciccarelli, E., Stiévenart, M. & Christophe, J. (1993) Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor. Biochem. Biophys. Res. Commun. 195, 881-888.
9. Spengler, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburg, P. H. & Journot, L. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365, 170-175.
10. Robberecht, P., Cauvin, A., Gourlet, P. & Christophe, J. (1990) Heterogeneity of VIP receptors. Arch. Int. Pharmacodyn. Ther. 303, 51-66.
11. Robberecht, P., Waelbroeck, M., De Neef, P., Tastenoy, M., Gourlet, P., Cogniaux, J. & Christophe, J. (1988) A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts. FEBS Lett. 228, 351-355.
12. Ishihara, T., Shigemoto, R., Mori, K., Takahashi, K. & Nagata, S. (1992) Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8, 811-819.
13. Sreedharan, S. P., Patel, D. R., Huang, J.-X. & Goetzl, E. J. (1993) Cloning and functional expression of a human neuroendocrinc vasoactive intestinal peptide receptor. Biochem. Biophys. Res. Commun. 193, 546-553.
14. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334, 3-8.
15. Inagaki, N., Yoshida, H., Mizuta, M., Mizuno, N., Fujii, Y., Gonoi, T., Miyazaki, J.-I. & Seino, S. (1994) Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl Acad. Sci. USA 91, 2679-2683.
16. Svoboda, M., Tastenoy, M., Van Rampelbergh, J., Goossens, J.-F., De Neef, P., Waelbroeck, M. & Robberecht, P. (1994) Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205, 1617-1624.
17. Ciccarelli, E., Vilardaga, J. P., De Neef, P., Di Paolo, E., Waelbroeck, M., Bollen, A. & Robberecht, P. (1994) Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regul. Pept. 54, 397-407.
18. Ciccarelli, F., Svoboda, M., De Neef, P., Di Paolo, E., Bollen, A., Dubeaux, C., Vilardaga, J.-P. Waelbroeck, M. & Robberecht, P. (1995) Pharmacological properties of two recombinant splice variants of the PACAP type I receptor transfected and stably expressed in CHO cells. Eur. J. Pharmacol. 288, 259-267.
19. Vilardaga, J. P., Ciccarelli, E., Dubeaux, C., De Neef, P., Bollen, A. & Robberecht, P. (1994) Properties and regulation of the coupling to adenylate cyclase of the secretin receptor stably transfected in CHO cells. Mol. Pharmacol. 45, 1022-1028.
20. Vilardaga, J.-P., De Neef, P., Di Paolo, E., Bollen, A., Waelbroeck, M. & Robberecht, P. (1995) Properties of chimeric and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. Biochem. Biophys. Res. Commun. 211, 885-891.
21. Vilardaga, J.-P., Di Paolo, E. & Bollen, A. (1995) Improved PCR method for high-efficiency site-directed mutagenesis using class 2S restriction enzymes. Biotechniques 18, 605-606.
22. Fraker, P. J. & Speck, J. C. Jr (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
23. Waelbroeck, M., Robberecht, P., De Neef, P., Chatelain, P. & Christophe, J. (1981) Binding of vasoactive intestinal peptide (VIP) d VIP-stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments. Biochim. Biophys. Acta 678, 83-90.
24. Salomon, Y., Londos, C. & Rodbell, M. (1974) A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541-548.
25. Robberecht, P., Conlon, T. P. & Gardner, J. D. (1976) Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the guinca pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular adenosine 3′,5′-monophosphate. J. Biol. Chem. 251, 4635-4639.
26. Couvineau, A., Rouyer-Fessard, C., Fournier, A., St-Pierre, S., Pipkorn, R. & Laburthe, M. (1984) Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: effect of nine partial sequences. Biochem. Biophys. Res. Commun. 121, 493 498.
27. Robberecht, P., Gourlet, P. De Neef, P. Woussen-Colle, M.-C., Vandermeers-Piret, M.-C., Vandermeers, A. &. Christophe, J. (1992) Receptor occupancy and adenylate cyclase activation in AR 4-2J rat pancreatic acinar cell membranes by analogs of pituitary adenylate cyclase-activating peptides amino-terminally shortened or modified at position 1,2,3,20, or 21. Mol. Pharmacol. 42, 347-355.
28. Schäfer, H. & Schmidt, W. E. (1993) Characterization and purification of the solubilized pituitary adenylate-cyclase-activating polypeptide-1 receptor from porcine brain using a biotinylated ligand. Eur. J. Biochem. 217, 823-830.
29. O'Donnell, M., Garippa, R. J., O'Neill, N. C., Bolin, D. R. & Cottrell, J. M. (1991) Structure-activity studies of vasoactive intestinal polypeptide. J. Biol. Chem. 266, 6389-6392.
30. Olson, G. L., Bolin, D. R., Bonner, M. P., Bös, M., Cook, C. M., Fry, D. C., Graves, B. J., Hatada, M. Hill, D. E., Kahn, M., Madison, V. S., Rusiecki, V. K., Sarabu, R., Sepinwall, J., Vincent, G. P. & Voss, M. E. (1993) Perspective. Concepts and progress in the development of peptide mimeties. J. Med. Chem. 36, 3039-3049.
31. Bodanszky, M., Natarajan, S., Gardner, J. D., Makhlouf, G. M. & Said, S. I. (1978) Synthesis and some pharmacological properties of the 23-amino acids peptide 15-lysine secretin (5 27). Special role of the residue in position 15 in biological activity of the vasoactive intestinal peptide. J. Med. Chem. 21, 1171-1173.
32. Gardner, J. D., Conlon, T. P., Fink, M. L. & Bodanszky, M. (1976) Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. Gastroenterology 71, 965-970.
33. Bodanszky, M. & Bodanszky, A. (1982) Synthesis of VIP and related peptides: structure activity relationships, in Vasoactive intestinal peptide (Said. S. I., ed.) pp. 11-22. Raven Press, New York.
34. Clore, G. M., Nilges, M., Brünger, A. & Gronenborn, A. M. (1988) Determination of the backbone conformation of secretin by restrained molecular dynamics on the basis of interproton distance data. Eur. J. Biochem. 171, 479-484.
35. Murphy, W. A., Coy, D. H. & Lance, V. A. (1986) Superactive amidated COOH-terminal glucagon analogues with no methionine or tryptophan. Peptides 7, 69-74.
36. Taylor, J. W. Kaiser, E. T. (1986) The structural characterization of β-endorphin and related peptide hormones and neurotransmitters. Pharmacol. Rev. 38, 291-319.
37. Wray, V., Kakoschke, C., Nokihara, K. & Naruse, S. (1993) Solution structure of pituitary adenylate cyclase activating polypeptide by nuclear magnetic resonance spectroscopy. Biochemistry 32, 5832-5841.
38. Hibert, M. F., Trumpp-Kallmeyer, S., Hoflack, J. & Bruinvels, A. (1993) This is not a G protein-coupled receptor. Trends Pharmacol. Sci. 14, 7-12.
39. LaRosa, G. J., Thomas, K. M., Kaufmann, M. E., Mark, R., White, M., Taylor, L., Gray, G., Witt, D. & Navarro, J. (1992) Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J. Biol. Chem. 267, 25402-25406.
40. Yokota, Y., Akazawa, C., Ohkubo, H. & Nakanishi, S. (1992) Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors. EMBO J. 11, 3585-3591.
41. . Hashido, K., Gamou, T., Adachi, M., Tabuchi, H., Watanabe, T., Furuichi, Y. & Miyamato, C. (1992) Truncation of N-terminal extracellular or C-terminal intracellular domains of human ETA receptor abrogated the binding activity to ET-1. Biochem. Biophys. Res. Commun. 187, 1241-1248.
42. Xie, Y.-B., Wang, H. & Segaloff, D. L. (1990) Extracellular domain of lutropin/choriogonadotropin receptor expressed in transfected cells binds choriogonadotropin with high affinity. J. Biol. Chem. 265, 21411-21414.
43. . Nagayama, Y., Wadsworth, H. L., Chazenbalk, G. D., Russo, D., Seto, P. & Rapoport, B. (1991) Thyrotropin-luteinizing hormone/ chorionic gonadotropin receptor extracellular domain chimeras as probes for thyrotropin receptor function. Proc. Natl Acad. Sci. USA 88, 902-905.
44. Stroop, S. D., Kuestner, R. E., Serwold, T. F., Chen, L. & Moore, E. E. (1995) Chimeric human calcitonin and glucagon receptors reveal two dissociable calcitonin interaction sites. Biochemistry 34, 1050-1057.